Profile
Geoffrey S.
Gilmartin worked as a Medical Director-Clinical Development at Vertex Pharmaceuticals, Inc. from 2011 to 2014.
He also worked as the Director of BIDMC Sleep Disorders Center at Beth Israel Deaconess Medical Center, Inc. Additionally, he was the Chief Medical Affairs Officer at Proteostasis Therapeutics, Inc. in 2019.
Gilmartin received his undergraduate degree from Dartmouth College, his graduate degree from Harvard Medical School, and his doctorate from The Warren Alpert Medical School.
Former positions of Geoffrey S. Gilmartin
| Companies | Position | End |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 2013-12-31 |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| PROTEOSTASIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Geoffrey S. Gilmartin
| Dartmouth College | Undergraduate Degree |
| Harvard Medical School | Graduate Degree |
| The Warren Alpert Medical School | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 2 |
|---|---|
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Geoffrey S. Gilmartin
